FDA Inspection 1018165 — Department of Defense - Army (Armed Services Blood Program)
The FDA completed an inspection of Department of Defense - Army (Armed Services Blood Program) on May 25, 2017 in Landstuhl. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 25, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Landstuhl (Germany)